Rapid Micro Biosystems (RPID) Receivables - Net (2020 - 2026)

Rapid Micro Biosystems has disclosed Receivables - Net across 7 years of filings, most recently posting $6.4 million for Q1 2026.

• Receivables - Net for Q1 2026 came in at $6.4 million, up 40.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 40.83% YoY), and the FY2025 annual result was $3.1 million, down 58.32% from the prior year.
• Receivables - Net came in at $6.4 million for Q1 2026 at Rapid Micro Biosystems, up from $3.1 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $7.5 million in Q4 2024 to a low of $3.1 million in Q4 2025.
• The 5-year median for Receivables - Net is $4.9 million (2024), against an average of $4.9 million.
• Peak annual rise in Receivables - Net reached 45.19% in 2025, while the deepest fall reached 58.32% in 2025.
• Rapid Micro Biosystems' Receivables - Net stood at $5.4 million in 2022, then grew by 3.04% to $5.5 million in 2023, then surged by 35.92% to $7.5 million in 2024, then slumped by 58.32% to $3.1 million in 2025, then jumped by 103.16% to $6.4 million in 2026.
• The last three Receivables - Net figures came in at $6.4 million (Q1 2026), $3.1 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.